Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kalvista Pharmaceuticals (KALV) Q4 2025 Earnings
KALV
10
Nov
Confirmed
Q1 2025
Q3 2025
Q3 2025
Q4 2025
-1.12
-0.97
-0.82
-0.67
Details
Expected EPS
-0.672222
Actual EPS
-0.92
Surprise EPS
-0.25
Surprise Percent
+36.86%
Description
Kalvista Pharmaceuticals (KALV) has reported earnings of -0.92 per share for Q4 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login